Fundz
You are reading one round. Fundz also knows which of your own LinkedIn connections can open this account.See it live →

H Clinical, Inc. secures majority investment from Emerald Square Ventures to enhance clinical research staffing and patient recruitment across Latin America.

PRIVATESep 16, 2026about 3 hours ago

Round Type

Venture - Series Unknown

Saint PetersburgBiotechnologyHealth CareMedical

Investors

Emerald Square Ventures

Description

H Clinical, Inc. has announced a majority investment from Emerald Square Ventures to support the expansion of their in-country clinical research capabilities. This investment will enhance staffing, patient recruitment, and hybrid delivery for sponsors and CROs in Latin America. With new leadership additions, H Clinical aims to improve client services through community connections

Company Information

Company

H Clinical

Location

Saint Petersburg, Florida, United States

About

H Clinical is the leading clinical research operating platform in Latin America, working through its own in-country teams across 22 countries. It supports sponsors, contract research organizations, and research sites with clinical research staffing, in-home trial support, community-based patient recruitment, and procurement logistics. H Clinical empowers sponsors to reach patients that usual channels miss. The company operates the largest in-home trial, mobile site, logistics and depot network in the region.

Don't miss H Clinical's next move

Get an email the moment H Clinical raises, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for H Clinical's next move

See what Strategic adds

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

H Clinical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.